What changed
$WRB — BUY 📊
W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide.
🎯 Q2 2026 | Rev $4B | EPS $1.30 vs $1.14 🟢
💡 Consensus expected EPS of 1.14 but actual came in at 1.30, implying earnings power is materially above estimates. The market likely still discounts a mean-reversion in margins that hasn't materialized. The gap will close as forward estimates rise.
📉 Reward/risk: 1.51:1
🏢 Business Quality: 8/10
📊 Valuation: fair
🔮 Catalyst: Recent Q1 2026 earnings beat and upcoming conference call guidance raise
💰 Entry: $69.49, stop $62.54, target $80.0
⚖️ Buy WRB at $69.49 with a stop at $62.54 and target $80, capitalizing on the gap between reported earnings power and still-conservative consensus; upside 15% vs 10% risk.
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/WRB0625
Also in play: $PWR $PRIM $MYRG $EME $APG
Why it matters
W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide.